China Universal Asset Management »

Amicus Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $669k 57k 11.79
2023-12-31 $481k 34k 14.18
2023-09-30 $90k 7.4k 12.22
2023-06-30 $47k 3.7k 12.60
2023-03-31 $42k 3.8k 11.03
2022-12-31 $35k 2.9k 12.26
2022-09-30 $27k 2.6k 10.28

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
BlackRock
Jpmorgan Chase & Co
Wellington Management Company
Redmile Group
William Blair Investment Management
Henderson Group
Palo Alto Investors
Deutsche Bank Aktiengesellschaft
Fiera Capital Corporation
Artal Group
Bank of America Corporation
Norges Bank Investment Management

View all funds holding Amicus Therapeutics